MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

MindWalk Holdings Corp.NASDAQ: HYFT

Capital Expenditures · Q3 FY2026 · quarter ended Jan 2026

Capital expenditures declines year over year

Q3 FY2026 capital expenditures of CA$30.58K (cash outflow) fell 72.7% year over year, behind the -52.4% change in trailing-twelve-month capital expenditures. Sequentially, it fell 58.7% from the prior quarter. Over 3 fiscal years it compounded at -14.0% a year.

Context

  • Capital expenditures amounted to 3.3% of revenue in FY2025, down 2.4 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -72.7% toward the trailing-twelve-month pace of -52.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJan 2026
-CA$30.58K-58.7% QoQ
Last fiscal yearApr 2025
-CA$799K-42.8% YoY
LTMJan 2026
-CA$745.58K-52.4% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-72.7%——
1 year-42.8%——
3-year CAGR-14.0%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

CAD · from the cash flow

Latest · FY2025
(799K) CAD
Year-over-year change
+42.8%

Capital Expenditures vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -52.4% is the 5th highest of 8, against a peer median of -43.7%.
  • Capital expenditures amounts to 4.1% of revenue for HYFT, versus a peer median of 14.6%.
HYFT Competitors
Capital Expenditures for HYFT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$745.58K CAD-52.4%-14.0%4.1%
ATYRaTyr Pharma, Inc.LTM Mar 2026$215K USD+347.9%-63.9%113.2%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$202K USD-43.7%-47.0%—
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$109K USD-90.6%+115.1%—
CLNNClene Inc.LTM Mar 2026$39K USD+874.9%-80.4%29.1%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$16K USD-80.5%+128.9%—
BYSIBeyondSpring Inc.LTM Mar 2026$543 USD-98.9%+13.7%—
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$0 USD+100.0%—0.0%
FBIOFortress Biotech, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding HYFT) —-43.7%-16.7%14.6%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Net Income(7.34M)(16.71M)(26.56M)(27.18M)(30.23M)
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
Deferred Income Tax(83K)(336K)(926K)(1.77M)(3.94M)
Stock-Based Compensation2.75M3.08M1.94M1.54M445K
Change in Working Capital(1.02M)582K(3.28M)2.4M276.99K
Accounts Receivables(439K)163K(561K)(241K)(391.8K)
Inventory(316K)(501K)(185K)(102K)99.03K
Accounts Payables(73K)781K(1.55M)994.8K593.45K
Other Working Capital(190K)139K(976K)1.75M(23.68K)
Other Non-Cash Items1.38M(310K)2.3M15.03M21.92M
Operating Cash Flow(600K)(9.92M)(19.83M)(4.25M)(6.41M)
Capital Expenditures(1.43M)(1.26M)(1.5M)(1.4M)(799K)
Acquisitions (Net)(1.03M)(3.69M)(592K)(146K)0
Purchases of Investments00000
Sales of Investments0080K121K0
Other Investing Activities0(259K)40K(141K)0
Investing Cash Flow(2.46M)(5.21M)(1.97M)(1.56M)(799K)
Debt Repayment(772K)(962K)(1.34M)(1.34M)2.67M
Common Stock Issued44.15M3.85M716K1.75M12.23M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(5K)0612.26K0
Financing Cash Flow43.38M2.88M(621K)1.02M14.89M
Effect of Forex Changes(1.18M)455K740K(33K)(438K)
Net Change in Cash39.15M(11.79M)(21.68M)(4.82M)7.25M
Free Cash Flow(2.03M)(11.18M)(21.33M)(5.64M)(7.21M)

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.